Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Faces “Conundrum” In Determining Efficacy Of Children’s Cold Products

This article was originally published in The Tan Sheet

Executive Summary

FDA Office of New Drugs Director John Jenkins is uncertain the efficacy of OTC cough/cold ingredients can be accurately assessed in a pediatric population
Advertisement

Related Content

Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Sharfstein Takes “Acting” Title Literally, Starting FDA Overhaul
Race For White Oak Almost Over: Will It End With Sharfstein Or Califf At FDA?
Calls For Cough/Cold Collaboration As FDA Inches Toward Rulemaking
FDA Working Group Considering Changes To OTC Cough/Cold Monograph
FDA Panel Narrowly Votes Against Cough/Cold Drugs For Children Up To Age 6
FDA Panel Narrowly Votes Against Cough/Cold Drugs For Children Up To Age 6
Infant Cold Products Pulled; Waxman Looks For More OTC Risks
Advertisement
UsernamePublicRestriction

Register

PS102167

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel